Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS (full – 2010)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109320/
Distribution and function of the endocannabinoid system in the rat and human bladder (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/23081739
Activation of Cannabinoid Receptor 2 Inhibits Experimental Cystitis (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652164/
Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629438/
Functional relevance of the cannabinoid receptor 2 - heme oxygenase pathway: A novel target for the attenuation of portal hypertension (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24007798
Treatment with a Cannabinoid Receptor 2 Agonist Decreases Severity of Established Cystitis (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24184363
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24342422
Distribution and function of the endocannabinoid system in the rat and human bladder (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/23081739
Activation of Cannabinoid Receptor 2 Inhibits Experimental Cystitis (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652164/
Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629438/
Functional relevance of the cannabinoid receptor 2 - heme oxygenase pathway: A novel target for the attenuation of portal hypertension (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24007798
Treatment with a Cannabinoid Receptor 2 Agonist Decreases Severity of Established Cystitis (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24184363
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24342422